|
|
Clinical effect of Dexzopiclone combined with Flupentixol and Melitracen in the treatment of insomnia with depression and (or) anxiety |
SHI Lin-juan1 LI Hui-mian2▲ |
1.Department of Neurorehabilitation,the Second Affiliated Hospital of Zhengzhou University,He′nan Province,Zhengzhou 450000,China;
2.Department of Geriatrics,the Second Affiliated Hospital of Zhengzhou University,He′nan Province,Zhengzhou 450000,China |
|
|
Abstract Objective To investigate the clinical effect of Dexzopiclone combined with Flupentixol and Melitracen in the treatment of insomnia with depression and(or)anxiety.Methods A retrospective analysis was performed on 144 cases of insomnia with depression and (or) anxiety admitted to our hospital from January 2018 to January 2019 were selected as the study subjects.According to the different medication methods,they were divided into group A (n=46),group B (n=48),and group C (n=50).Group A was treated with Dexzopiclone,group B was treated with Flupentixol and Melitracen,and group C was treated with Dexzopiclone combined with Flupentixol and Melitracen.The scores of Pittsburgh sleep quality index (PSQI),Hamilton depression scale (HAMD) and Hamilton anxiety scale (HAMA) were compared among the three groups.The treatment emergent symptom scale (TESS) score and adverse reactions were compared among the three groups.Results The HAMD and HAMA scores of patients in group B and C after treatment were lower than those of group A,the differences were statistically significant (P<0.05).There was no significant difference in HAMD and HAMA scores between group B and group C (P>0.05).The PSQI score of group C after treatment was lower than that of group A and group B,the difference was statistically significant (P<0.05).There was no significant difference in TESS score and total incidence of adverse reactions among the three groups (P>0.05).Conclusion The patients of insomnia with depression and (or) anxiety were treated with Dexzopiclone Tablets combined with Flupentixol and Melitracen,the patients′ clinical anxiety and depression were significantly improved and well tolerated,worthy of clinical application.
|
|
|
|
|
[1] |
黎玉宣,匡家毅,王希琳,等.针刺脐环穴结合温针涌泉穴对心肾不交型失眠症患者睡眠质量、抑郁及焦虑评分的影响[J].广西医学,2018,40(9):1094-1096.
|
[2] |
程毅东.雷贝拉唑联合氟哌噻吨美利曲辛治疗非糜烂性胃食管反流病伴焦虑抑郁患者的效果[J].现代消化及介入诊疗,2017,22(2):223-225.
|
[3] |
孙群,姚惠香.雷贝拉唑联合氟哌噻吨美利曲辛治疗非糜烂性胃食管反流病的临床观察[J].上海交通大学学报(医学版),2014,34(3):352-356,360.
|
[4] |
王丹,张丽莉.氟哌噻吨美利曲辛联合布拉酵母菌治疗伴焦虑抑郁症状的腹泻型肠易激综合征患者的效果观察[J].河北医药,2018,40(4):497-501.
|
[5] |
彭涛,刘玉兰,夏志伟,等.氟哌噻吨美利曲辛联合布拉酵母菌治疗伴有焦虑抑郁状态的腹泻型肠易激综合征患者的疗效评估[J].中华消化杂志,2015,35(2):122-126.
|
[6] |
徐杲,华娴,徐希,等.氟哌噻吨美利曲辛联合质子泵抑制剂对伴焦虑抑郁的非糜烂性胃食管反流病的临床疗效[J].医学研究杂志,2016,45(1):138-140,162.
|
[7] |
侯慧,荣亮.氟哌噻吨美利曲辛联合质子泵抑制剂对伴焦虑抑郁的非糜烂性胃食管反流病的临床效果观察[J].胃肠病学和肝病学杂志,2014,23(7):755-758.
|
[8] |
徐涛,王华英,俞万钧.吸氧联合右佐匹克隆对轻度上气道塌陷阻塞性睡眠呼吸暂停低通气综合征患者的疗效研究[J].中华全科医学,2018,16(10):1639-1642.
|
[9] |
郭宇宙,于子浇,刘红爱,等.养血清脑颗粒对脑卒中后睡眠障碍患者症状改善及血清5-HT、BDNF水平的影响[J].疑难病杂志,2017,16(5):457-460.
|
[10] |
王璞,周佩洋,张贵斌.养血清脑颗粒联合艾司唑仑治疗脑卒中后睡眠障碍疗效及对血清5-HT、BDNF水平的影响[J].现代中西医结合杂志,2019,28(3):318-321.
|
[11] |
钟辉,龚冬梅.氟哌噻吨美利曲辛联合PPI制剂治疗非糜烂性胃食管反流病的近期疗效及安全性[J].实用药物与临床,2017,20(2):154-158.
|
[12] |
黄松林,李哮天.氟哌噻吨美利曲辛联合雷贝拉唑治疗非糜烂性胃食管反流病伴抑郁焦虑患者的疗效观察[J].广西医学,2017,39(1):100-102.
|
[13] |
王飞龙,周斌,张军.雷贝拉唑联合氟哌噻吨美利曲辛治疗非糜烂性胃食管反流病伴焦虑抑郁的临床观察[J].中国药房,2014,25(48):4551-4553.
|
[14] |
李迪,李增男,薛刚刚,等.较低剂量氟哌噻吨美利曲辛联合雷贝拉唑和莫沙必利对非糜烂性胃食管反流病伴述情障碍患者的疗效观察[J].中国医药,2016,11(1):62-66.
|
[15] |
路改英.氟哌噻吨美利曲辛联合雷贝拉唑治疗非糜烂性胃食管反流病伴焦虑抑郁的效果观察[J].中国实用医刊,2018,45(21):96-97,100.
|
|
|
|